Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic.

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad.

Kow CS; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com.
Ramachandram DS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

Med Clin (Barc) ; 159(9): e61, 2022 11 11.

Article in English, Spanish | MEDLINE | ID: covidwho-1936977

Subject(s)

Atrial Fibrillation; COVID-19; Stroke; Humans; Atrial Fibrillation/complications; Atrial Fibrillation/drug therapy; Pandemics; Anticoagulants/adverse effects; Warfarin/therapeutic use; Administration, Oral; Stroke/epidemiology; Stroke/etiology; Stroke/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English / Spanish Journal: Med Clin (Barc) Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google